ANDREEA SEICEAN: Open Payments
NPI 1518354414 · ROCKVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,311 in 57 payments from 11 companies in 2025. Trend: 2023 $826 · 2024 $857 · 2025 $1,311
Food & beverage: $1,311
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $226 |
| Axsome Therapeutics, Inc. | 8 | $223 |
| Lundbeck LLC | 8 | $201 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $166 |
| Corium, LLC | 5 | $116 |
| Collegium Pharmaceutical, Inc. | 5 | $109 |
| Otsuka America Pharmaceutical, Inc. | 3 | $81 |
| Tris Pharma Inc | 4 | $75 |
| Vertical Pharmaceuticals, LLC | 3 | $64 |
| E.R. Squibb & Sons, L.L.C. | 1 | $30 |
Products named: REXULTI, VRAYLAR, Sunosi, CAPLYTA, Azstarys, Jornay PM, Dyanavel XR, Relexxii.
Industry payments across MD — which companies pay providers there.
